Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease.

Journal of visceral surgery - 1 Oct 2017

Turrini O, Gilabert M, Ewald J, Moutardier V, Delpero J-R, Iovanna J-L

Abstract excerpt

PURPOSE: To assess the K-ras gene mutation in the histologically negative venous margin of a pancreaticoduodenectomy (PD) specimen and its impact on survival. METHOD: From 2007 to 2010, 22 patients underwent R0 PD for resecable pancreatic adenocarcinoma. All specimens were stained and the portal vein (PV) bed was identified by blue ink; a 2mm3 sample (including the blue ink) was cut from a microscopic free-tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Pancreatic Neoplasms

Share to Portal Vein

Share to Proto-Oncogene Proteins p21(ras)

Share to Risk Assessment

Share to Survival Analysis

Source

Identifiers

PMID: 28844705
DOI: 10.1016/j.jviscsurg.2017.05.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease.PMID 28844705Read ↗

KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrenceSemantic proximity Read ↗

Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.Semantic proximity Read ↗

KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.Semantic proximity Read ↗

Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?Semantic proximity Read ↗

KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance.Semantic proximity Read ↗

RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.Semantic proximity Read ↗

Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer.Semantic proximity Read ↗

Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.Semantic proximity Read ↗

Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.Semantic proximity Read ↗

A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.